IRIS Accounts Production v26.1.0.640 06733505 Board of Directors 1.4.24 31.3.25 31.3.25 0 0 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh067335052024-03-31067335052025-03-31067335052024-04-012025-03-31067335052023-03-31067335052023-04-012024-03-31067335052024-03-3106733505ns15:EnglandWales2024-04-012025-03-3106733505ns14:PoundSterling2024-04-012025-03-3106733505ns10:Director12024-04-012025-03-3106733505ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3106733505ns10:SmallEntities2024-04-012025-03-3106733505ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3106733505ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3106733505ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3106733505ns10:FullAccounts2024-04-012025-03-310673350512024-04-012025-03-3106733505ns10:Director22024-04-012025-03-3106733505ns10:CompanySecretary12024-04-012025-03-3106733505ns10:RegisteredOffice2024-04-012025-03-3106733505ns5:CurrentFinancialInstruments2025-03-3106733505ns5:CurrentFinancialInstruments2024-03-3106733505ns5:ShareCapital2025-03-3106733505ns5:ShareCapital2024-03-3106733505ns5:RetainedEarningsAccumulatedLosses2025-03-3106733505ns5:RetainedEarningsAccumulatedLosses2024-03-3106733505ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3106733505ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-04-012025-03-3106733505ns5:PlantMachinery2024-04-012025-03-3106733505ns5:ComputerEquipment2024-04-012025-03-3106733505ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-03-3106733505ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-03-3106733505ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-03-3106733505ns5:PlantMachinery2024-03-3106733505ns5:ComputerEquipment2024-03-3106733505ns5:PlantMachinery2025-03-3106733505ns5:ComputerEquipment2025-03-3106733505ns5:PlantMachinery2024-03-3106733505ns5:ComputerEquipment2024-03-3106733505ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3106733505ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-31
REGISTERED NUMBER: 06733505 (England and Wales)


















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

FOR

LONDON MEDICAL DESIGN LIMITED

LONDON MEDICAL DESIGN LIMITED (REGISTERED NUMBER: 06733505)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


LONDON MEDICAL DESIGN LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: C Natali
A Sivaraman





SECRETARY: A Sivaraman





REGISTERED OFFICE: 8 Glendale Close
Shenfield
Brentwood
Essex
CM15 8DB





REGISTERED NUMBER: 06733505 (England and Wales)





ACCOUNTANTS: Arithma LLP
Chartered Certified Accountants
5 Jardine House
Harrovian Business Village
Bessborough Road
Harrow
Middlesex
HA1 3EX

LONDON MEDICAL DESIGN LIMITED (REGISTERED NUMBER: 06733505)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £   
FIXED ASSETS
Intangible assets 4 1 1
Tangible assets 5 5,637 4,279
5,638 4,280

CURRENT ASSETS
Debtors 6 410,097 382,008
Cash at bank and in hand 100 7,665
410,197 389,673
CREDITORS
Amounts falling due within one year 7 (14,975 ) (24,834 )
NET CURRENT ASSETS 395,222 364,839
TOTAL ASSETS LESS CURRENT
LIABILITIES

400,860

369,119

PROVISIONS FOR LIABILITIES (1,071 ) (813 )
NET ASSETS 399,789 368,306

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 399,787 368,304
SHAREHOLDERS' FUNDS 399,789 368,306

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

LONDON MEDICAL DESIGN LIMITED (REGISTERED NUMBER: 06733505)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 April 2025 and were signed on its behalf by:





A Sivaraman - Director


LONDON MEDICAL DESIGN LIMITED (REGISTERED NUMBER: 06733505)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

London Medical Design Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

INTANGIBLE ASSETS
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of five years.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 33% on reducing balance

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2024 - NIL).

LONDON MEDICAL DESIGN LIMITED (REGISTERED NUMBER: 06733505)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


4. INTANGIBLE FIXED ASSETS
Developme
costs
£   
COST
At 1 April 2024
and 31 March 2025 6,474
AMORTISATION
At 1 April 2024
and 31 March 2025 6,473
NET BOOK VALUE
At 31 March 2025 1
At 31 March 2024 1

5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 April 2024 2,039 6,590 8,629
Additions 2,000 1,128 3,128
At 31 March 2025 4,039 7,718 11,757
DEPRECIATION
At 1 April 2024 1,034 3,316 4,350
Charge for year 460 1,310 1,770
At 31 March 2025 1,494 4,626 6,120
NET BOOK VALUE
At 31 March 2025 2,545 3,092 5,637
At 31 March 2024 1,005 3,274 4,279

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 1,502 6,697
Other debtors 408,595 375,311
410,097 382,008

LONDON MEDICAL DESIGN LIMITED (REGISTERED NUMBER: 06733505)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 1,310 -
Taxation and social security 12,947 17,083
Other creditors 718 7,751
14,975 24,834

8. RELATED PARTY DISCLOSURES

Debtors include £246,690 (2024 - £219,074) receivable from Sivaraman Limited, Nil (2024 - £274) from London Medical Consultants Limited and £141,572 (2024 - £140,073) from Colin Natali Limited. £8,381 (2024 - £7,893) was due from Mr C Natali and £6,847 (2024 - £3,098) was due from Mr A Sivaraman as at the balance sheet date. Interest has been charged to Mr. C Natali and Mr A Sivaraman.